Derrell Porter, Director at Acumen Pharmaceuticals, Inc. (ABOS), sold 32,300 shares at $2.35 ($75K) on 2026-06-15, disclosed to the SEC on 2026-06-17.
Open-market sale of $75k ABOS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.35 | 6,460 | $15K | 20.1% |
| 2 | $2.33 | 12,800 | $30K | 39.6% |
| 3 | $2.33 | 13,040 | $30K | 40.3% |
| Total | $2.33 avg | 32,300 | $75K | 100% |
| Filing → |
| ATRA | SELL | 2018-05-08 | $124K | — | Filing → |